Fuchs, Hendrik <br/><br/>
A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice.  [electronic resource] 

 -  Journal of controlled release : official journal of the Controlled Release Society  Feb 2007 
 - 342-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0168-3659 
<br/><br/><label>Standard No.: </label>10.1016/j.jconrel.2006.11.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine Transaminase--metabolism<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Aspartate Aminotransferases--metabolism<br/>Blotting, Western<br/>Body Weight--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Delivery Systems<br/>Enzyme-Linked Immunosorbent Assay<br/>ErbB Receptors--biosynthesis<br/>Escherichia coli--genetics<br/>Immunotoxins--administration & dosage<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasms--drug therapy<br/>Plasmids--genetics<br/>Transfection